These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
87 related items for PubMed ID: 8167718
1. Analysis of MHC class II transcription in two type III bare lymphocyte syndrome patients of a single family. Lambert M, Van Eggermond M, Verheij C, Van Ree J, Van den Elsen P. Immunodeficiency; 1993; 4(1-4):277-84. PubMed ID: 8167718 [No Abstract] [Full Text] [Related]
2. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Steimle V, Otten LA, Zufferey M, Mach B. Cell; 1993 Oct 08; 75(1):135-46. PubMed ID: 8402893 [Abstract] [Full Text] [Related]
3. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression. Long AB, Ferguson AM, Majumder P, Nagarajan UM, Boss JM. Mol Immunol; 2006 Feb 08; 43(5):395-409. PubMed ID: 16337482 [Abstract] [Full Text] [Related]
4. Differential inducibility of HLA class I and II antigens by r-IFN gamma in type III bare lymphocyte syndrome. Andrien M, Stordeur P, Vamos E, Mascart Lemone F, Toungouz M, Monfils G, Dupont E. Transplant Proc; 1991 Feb 08; 23(1 Pt 1):441. PubMed ID: 1899309 [No Abstract] [Full Text] [Related]
5. Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease. Krawczyk M, Reith W. Tissue Antigens; 2006 Mar 08; 67(3):183-97. PubMed ID: 16573555 [Abstract] [Full Text] [Related]
6. Sequences and factors: a guide to MHC class-II transcription. Glimcher LH, Kara CJ. Annu Rev Immunol; 1992 Mar 08; 10():13-49. PubMed ID: 1590984 [Abstract] [Full Text] [Related]
7. Class II MHC transcriptional mutants are defective in higher order complex formation. Riley JL, Boss JM. J Immunol; 1993 Dec 15; 151(12):6942-53. PubMed ID: 8258702 [Abstract] [Full Text] [Related]
8. Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo. Kara CJ, Glimcher LH. J Immunol; 1993 Jun 01; 150(11):4934-42. PubMed ID: 8496595 [Abstract] [Full Text] [Related]
9. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B. EMBO J; 1997 May 15; 16(10):2851-60. PubMed ID: 9184229 [Abstract] [Full Text] [Related]
10. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells. Rigaud G, De Lerma Barbaro A, Nicolis M, Cestari T, Ramarli D, Riviera AP, Accolla RS. J Immunol; 1996 Jun 01; 156(11):4254-8. PubMed ID: 8666795 [Abstract] [Full Text] [Related]
17. Transcriptional silencing of RFXAP in MHC class II-deficiency. van Eggermond MC, Tezcan I, Heemskerk MH, van den Elsen PJ. Mol Immunol; 2008 May 01; 45(10):2920-8. PubMed ID: 18336911 [Abstract] [Full Text] [Related]
19. Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction. Bull M, van Hoef A, Gorski J. Mol Cell Biol; 1990 Jul 01; 10(7):3792-6. PubMed ID: 2113177 [Abstract] [Full Text] [Related]